Group One Trading’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
69,300
-100
-0.1% -$1.91K ﹤0.01% 2493
2025
Q4
$1.51M Buy
69,400
+400
+0.6% +$11.5K ﹤0.01% 2520
2025
Q3
$2.25M Buy
69,000
+4,100
+6% +$151K ﹤0.01% 2194
2025
Q2
$2.3M Sell
64,900
-8,500
-12% -$275K 0.01% 1994
2025
Q1
$2.49M Sell
73,400
-2,800
-4% -$100K 0.01% 1628
2024
Q4
$2.48M Sell
76,200
-42,900
-36% -$1.78M 0.01% 1729
2024
Q3
$5.8M Buy
119,100
+18,300
+18% +$975K 0.02% 920
2024
Q2
$4.46M Buy
100,800
+67,800
+205% +$3.13M 0.02% 876
2024
Q1
$1.85M Buy
33,000
+22,600
+217% +$1.36M 0.01% 1542
2023
Q4
$626K Buy
10,400
+5,400
+108% +$342K ﹤0.01% 2877
2023
Q3
$336K Hold
5,000
﹤0.01% 3325
2023
Q2
$345K Buy
5,000
+1,600
+47% +$105K ﹤0.01% 3402
2023
Q1
$164K Sell
3,400
-900
-21% -$44K ﹤0.01% 3851
2022
Q4
$215K Sell
4,300
-5,100
-54% -$247K ﹤0.01% 3802
2022
Q3
$384K Buy
9,400
+4,700
+100% +$221K ﹤0.01% 3493
2022
Q2
$259K Sell
4,700
-200
-4% -$8.45K ﹤0.01% 4044
2022
Q1
$178K Sell
4,900
-35,000
-88% -$1.38M ﹤0.01% 4917
2021
Q4
$1.86M Buy
+39,900
New +$2.02M ﹤0.01% 2685
2021
Q3
Sell
-200
Closed -$8K 8497
2021
Q2
$8K Buy
+200
New +$6.8K ﹤0.01% 7604

Other funds holding LEGN

Group One Trading's LEGN Position: Q1 2026 in Review

Group One Trading increased its Legend Biotech (LEGN) stake by 27% in Q1 2026, buying an estimated $208K and bringing the position to 50,910 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.

Group One Trading first reported a position in LEGN in Q1 2022 and has held it in 13 quarters since. The position peaked at $2.1M in Q3 2024. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Group One Trading held 50,910 shares of Legend Biotech worth $921K as of Q1 2026.
  • Group One Trading bought 10,934 Legend Biotech shares in Q1 2026, an estimated $208K.
  • Legend Biotech made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2802 holding.
  • Group One Trading first reported a position in Legend Biotech in Q1 2022 and has held it in 13 quarters since.
  • Group One Trading's Legend Biotech position peaked at $2.1M in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.